
Swissmedic to Enter GMP Information into EudraGMDP
The Swiss Agency for Therapeutic Products has begun entering GMP compliance information in the European Union’s EudraGMDP database.
On Feb. 21, 2019, the European Medicines Agency (EMA)
The EudraGMDP database holds manufacturing, import, and wholesale-distribution authorizations as well as GMP and good distribution practice certificates, providing compliance status online for industry stakeholders. The MRA between the EU and Switzerland was updated in August 2017 to include an amendment on data entry by Swissmedic to EudraGMDP.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.